Helsinki spinout Aiforia has raised an initial $15.4m in series B funding, bringing it halfway to the round’s target.

Aiforia, a Finland-based intelligent pathology technology spinout of University of Helsinki, has picked up €12.6m ($15.4m) in a first series B tranche led by cancer diagnostics technology provider Epredia’s UK division. The tranche featured Aktia Nordic Micro Cap and unnamed existing investors. The round’s target size is $30.8m. Founded in 2013 as Fimmic, Aiforia is…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.